These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16156346)

  • 41. The under-use of statin in type 2 diabetic patients attending diabetic clinics in Italy.
    Avogaro A; Guida P; Giorda C; Mannucci E; Medea G; Comaschi M; Velussi M; Armienti G; Zucchetti R;
    Nutr Metab Cardiovasc Dis; 2007 Jan; 17(1):32-40. PubMed ID: 17174224
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
    Ito MK; Talbert RL; Tsimikas S
    Pharmacotherapy; 2006 Jul; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interview: role of managed care in implementing NCEP-ATP III guidelines.
    Carver JC
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():7. PubMed ID: 12608153
    [No Abstract]   [Full Text] [Related]  

  • 45. [Lipid peroxidation, cardiovascular risk factors and statin].
    Bayés B
    Med Clin (Barc); 2011 Feb; 136(5):202-4. PubMed ID: 21145075
    [No Abstract]   [Full Text] [Related]  

  • 46. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).
    Assmann G; Benecke H; Neiss A; Cullen P; Schulte H; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):776-83. PubMed ID: 17001218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should we be more aggressive in the therapy against cardiovascular risk factors? Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?
    Stirban AO; Tschoepe D
    Diabetes Care; 2008 Feb; 31 Suppl 2():S226-8. PubMed ID: 18227490
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statins: are any questions unanswered?
    Kearney PM; Baigent C
    Curr Opin Lipidol; 2006 Aug; 17(4):418-25. PubMed ID: 16832166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Might a statin-oriented strategy be counterproductive in the treatment of diabetes mellitus?
    Mascitelli L; Pezzetta F; Goldstein MR
    Singapore Med J; 2008 Nov; 49(11):960-1. PubMed ID: 19037569
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of peroxisome proliferator-activated receptors on lipoprotein metabolism and glucose control in type 2 diabetes mellitus.
    Rosenson RS
    Am J Cardiol; 2007 Feb; 99(4A):96B-104B. PubMed ID: 17307062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are we lowering LDL cholesterol sufficiently?
    Barter P; Rye KA
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
    [No Abstract]   [Full Text] [Related]  

  • 52. Statin therapy in young adults: ready for prime time?
    Pletcher MJ; Hulley SB
    J Am Coll Cardiol; 2010 Aug; 56(8):637-40. PubMed ID: 20705221
    [No Abstract]   [Full Text] [Related]  

  • 53. Statins and diabetes risk: how real is it and what are the mechanisms?
    Robinson JG
    Curr Opin Lipidol; 2015 Jun; 26(3):228-35. PubMed ID: 25887679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statin-induced diabetes: perhaps, it's the tip of the iceberg.
    Goldstein MR; Mascitelli L
    QJM; 2011 Feb; 104(2):174-8. PubMed ID: 21118868
    [No Abstract]   [Full Text] [Related]  

  • 55. A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines.
    Kelly SC; Gonzalo R; Petrasko M
    S D Med; 2014 Aug; 67(8):320-3. PubMed ID: 25163226
    [No Abstract]   [Full Text] [Related]  

  • 56. Adherence to statin therapy saves $944 over 18 months.
    Manag Care; 2011 Jul; 20(7):47. PubMed ID: 21848200
    [No Abstract]   [Full Text] [Related]  

  • 57. Guidelines target many women for statins.
    Harv Womens Health Watch; 2002 Apr; 9(8):1-2. PubMed ID: 11959535
    [No Abstract]   [Full Text] [Related]  

  • 58. Fibrates in the treatment of dyslipidemias--time for a reassessment.
    Goldfine AB; Kaul S; Hiatt WR
    N Engl J Med; 2011 Aug; 365(6):481-4. PubMed ID: 21830963
    [No Abstract]   [Full Text] [Related]  

  • 59. Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk?
    Ma Y; Culver A; Rossouw J; Olendzki B; Merriam P; Lian B; Ockene I
    Ther Adv Cardiovasc Dis; 2013 Feb; 7(1):41-4. PubMed ID: 23238515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statin therapy and new-onset diabetes: a cause for concern?
    Preiss D
    Maturitas; 2012 Jun; 72(2):95-6. PubMed ID: 22445672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.